Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis

Frédéric Beugnet; Lénaïg Halos; Diane Larsen; Christa de Vos

doi:10.1051/parasite/2016014

All issues

Volume 23 (2016)

Parasite, 23 (2016) 14

Full HTML

Open Access

Research Article

Table 2.

Dosage recommendation for NexGard^® and Advocate^® according to European labels.

Group	Sample size	Product	Active ingredient(s)	Dose rate
1	8 dogs	Advocate^®	Imidacloprid 10% w/v and moxidectin 2.5% w/v spot on solution	> 1 kg to 4 kg: one 0.4 mL tube/dog; > 4 kg to 10 kg: one 1.0 mL tube/dog; > 10 kg to 25 kg: one 2.5 mL tube/dog; > 25 kg up to 40 kg: one 4.0 mL tube/dog
2	8 dogs	NexGard^®	Afoxolaner (2.27% w/w)	2 kg to 4 kg: 11 mg afoxolaner; > 4 kg to 10 kg: 28 mg afoxolaner; > 10 kg to 25 kg: 68 mg afoxolaner; > 25 kg to 50 kg: 136 mg afoxolaner.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.